SMUP-IA-01

Phase 1 clinical trial by MFDS approved53%
53%

Intra-articular Injectable treatment for osteoarthritis

SMUP-IA-01, SMUP allogeneic umbilical cord blood-derived mesenchymal stem cells, is currently under development for the treatment and prevention of Osteoarthritis. Currently, SMUP-IA-01 is undergoing Phase 1 clinical trial in Korea with IND from the MFDS.

Mechanism of Action for SMUP-IA-01

Related News

Menu